C M Goos - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C M Goos

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Oncotarget|July 15, 2015

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patientsKristiaan Lenos, Jeroen A C M Goos, Ilona M Vuist, et al.

British Journal of Cancer|November 18, 2016

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrenceSjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, et al.

British Journal of Cancer|September 5, 2013

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancerN Snoeren, B L Emmink, M J G Koerkamp, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Oncotarget|July 15, 2015

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patientsKristiaan Lenos, Jeroen A C M Goos, Ilona M Vuist, et al.

British Journal of Cancer|November 18, 2016

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrenceSjoerd H den Uil, Veerle M H Coupé, Janneke F Linnekamp, et al.

British Journal of Cancer|September 5, 2013

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancerN Snoeren, B L Emmink, M J G Koerkamp, et al.

Pageof 5